{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:58:18Z","timestamp":1791140298533,"version":"4.1.0"},"reference-count":111,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.mehy.2009.12.027","type":"journal-article","created":{"date-parts":[[2010,1,19]],"date-time":"2010-01-19T10:57:33Z","timestamp":1263898653000},"page":"276-281","source":"Crossref","is-referenced-by-count":19,"title":["Salsalate may have broad utility in the prevention and treatment of vascular disorders and the metabolic syndrome"],"prefix":"10.1016","volume":"75","author":[{"given":"Mark F.","family":"McCarty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.mehy.2009.12.027_bib1","doi-asserted-by":"crossref","first-page":"9052","DOI":"10.1073\/pnas.97.16.9052","article-title":"The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation","volume":"97","author":"Hajra","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.mehy.2009.12.027_bib2","first-page":"483","article-title":"Inhibition of nuclear factor-kappaB attenuates artherosclerosis in apoE\/LDLR \u2013 double knockout mice","volume":"56","author":"Jawien","year":"2005","journal-title":"J Physiol Pharmacol"},{"issue":"12","key":"10.1016\/j.mehy.2009.12.027_bib3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.molmed.2003.10.007","article-title":"Inflammation meets oxidation: NF-kappaB as a mediator of initial lesion development in atherosclerosis","volume":"9","author":"Kutuk","year":"2003","journal-title":"Trends Mol Med"},{"issue":"4","key":"10.1016\/j.mehy.2009.12.027_bib4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cardiores.2003.11.038","article-title":"Nuclear factor kappaB: a potential therapeutic target in atherosclerosis and thrombosis","volume":"61","author":"Monaco","year":"2004","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.mehy.2009.12.027_bib5","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cmet.2008.08.016","article-title":"Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis","volume":"8","author":"Gareus","year":"2008","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.mehy.2009.12.027_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1358\/dnp.2004.17.2.829042","article-title":"NF-kappaB and reperfusion injury","volume":"17","author":"Nichols","year":"2004","journal-title":"Drug News Perspect"},{"issue":"8","key":"10.1016\/j.mehy.2009.12.027_bib7","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00268-007-9112-5","article-title":"Pyrrolidine dithiocarbamate reduces lung injury caused by mesenteric ischemia\/reperfusion in a rat model","volume":"31","author":"Kabay","year":"2007","journal-title":"World J Surg"},{"issue":"44","key":"10.1016\/j.mehy.2009.12.027_bib8","doi-asserted-by":"crossref","first-page":"6960","DOI":"10.3748\/wjg.v11.i44.6960","article-title":"Nuclear factor-kappaB decoy oligodeoxynucleotides attenuates ischemia\/reperfusion injury in rat liver graft","volume":"11","author":"Xu","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.mehy.2009.12.027_bib9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/sj.gt.3302704","article-title":"Prevention of abdominal aortic aneurysms by simultaneous inhibition of NFkappaB and ets using chimeric decoy oligonucleotides in a rabbit model","volume":"13","author":"Miyake","year":"2006","journal-title":"Gene Ther"},{"issue":"24","key":"10.1016\/j.mehy.2009.12.027_bib10","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1161\/CIRCULATIONAHA.107.728303","article-title":"NF-kappaB is a key mediator of cerebral aneurysm formation","volume":"116","author":"Aoki","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.mehy.2009.12.027_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0014-5793(98)01034-5","article-title":"Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B","volume":"435","author":"Bond","year":"1998","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1016\/j.mehy.2009.12.027_bib12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1006\/bbrc.1999.1551","article-title":"Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts","volume":"264","author":"Bond","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.mehy.2009.12.027_bib13","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1161\/01.ATV.0000015078.09208.92","article-title":"Role of nuclear factor-kappa B activation in metalloproteinase-1, -3, and -9 secretion by human macrophages in vitro and rabbit foam cells produced in vivo","volume":"22","author":"Chase","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.mehy.2009.12.027_bib14","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1161\/CIRCRESAHA.107.148668","article-title":"Regression of abdominal aortic aneurysms by simultaneous inhibition of nuclear factor kappaB and ets in a rabbit model","volume":"101","author":"Miyake","year":"2007","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.mehy.2009.12.027_bib15","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1161\/ATVBAHA.108.180760","article-title":"Reduced collagen biosynthesis is the hallmark of cerebral aneurysm: contribution of interleukin-1beta and nuclear factor-kappaB","volume":"29","author":"Aoki","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.mehy.2009.12.027_bib16","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.4049\/jimmunol.162.7.4226","article-title":"Nuclear factor-kappa B mediates TNF-alpha inhibitory effect on alpha 2(I) collagen (COL1A2) gene transcription in human dermal fibroblasts","volume":"162","author":"Kouba","year":"1999","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.mehy.2009.12.027_bib17","doi-asserted-by":"crossref","first-page":"C58","DOI":"10.1152\/ajpcell.00314.2001","article-title":"NF-kappaB induced by IL-1beta inhibits elastin transcription and myofibroblast phenotype","volume":"283","author":"Kuang","year":"2002","journal-title":"Am J Physiol Cell Physiol"},{"issue":"12","key":"10.1016\/j.mehy.2009.12.027_bib18","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1161\/ATVBAHA.108.173898","article-title":"Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability","volume":"28","author":"Newby","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.mehy.2009.12.027_bib19","first-page":"57","article-title":"Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque","volume":"15","author":"Chen","year":"2005","journal-title":"Int J Mol Med"},{"issue":"17","key":"10.1016\/j.mehy.2009.12.027_bib20","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1161\/01.CIR.98.17.1707","article-title":"Nuclear factor-kappaB is selectively and markedly activated in humans with unstable angina pectoris","volume":"98","author":"Ritchie","year":"1998","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.mehy.2009.12.027_bib21","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jvs.2004.12.030","article-title":"Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-kappaB","volume":"41","author":"Parodi","year":"2005","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.mehy.2009.12.027_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2350-10-47","article-title":"Functional polymorphism of the NFKB1 gene promoter is related to the risk of dilated cardiomyopathy","volume":"10","author":"Zhou","year":"2009","journal-title":"BMC Med Genet"},{"issue":"11","key":"10.1016\/j.mehy.2009.12.027_bib23","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1096\/fj.05-5133fje","article-title":"Absence of NF-kappaB subunit p50 improves heart failure after myocardial infarction","volume":"20","author":"Frantz","year":"2006","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.mehy.2009.12.027_bib24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.cardiores.2005.11.027","article-title":"Inflammation and postinfarct remodeling: overexpression of IkappaB prevents ventricular dilation via increasing TIMP levels","volume":"69","author":"Trescher","year":"2006","journal-title":"Cardiovasc Res"},{"issue":"15","key":"10.1016\/j.mehy.2009.12.027_bib25","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1073\/pnas.0401060101","article-title":"Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis","volume":"101","author":"Monaco","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.mehy.2009.12.027_bib26","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.4049\/jimmunol.162.5.2939","article-title":"Selective regulation of cytokine induction by adenoviral gene transfer of IkappaBalpha into human macrophages: lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-kappaB independent","volume":"162","author":"Bondeson","year":"1999","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.mehy.2009.12.027_bib27","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.ATV.0000160340.72641.87","article-title":"Nuclear factor kappaB signaling in atherogenesis","volume":"25","author":"de Winther","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.mehy.2009.12.027_bib28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.atherosclerosis.2006.07.018","article-title":"Macrophage-specific inhibition of NF-kappaB activation reduces foam-cell formation","volume":"192","author":"Ferreira","year":"2007","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.mehy.2009.12.027_bib29","doi-asserted-by":"crossref","first-page":"C1493","DOI":"10.1152\/ajpcell.00016.2006","article-title":"ROS and NF-kappaB but not LXR mediate IL-1beta signaling for the downregulation of ATP-binding cassette transporter A1","volume":"292","author":"Chen","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"issue":"8","key":"10.1016\/j.mehy.2009.12.027_bib30","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1172\/JCI200318580","article-title":"Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice","volume":"112","author":"Kanters","year":"2003","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.mehy.2009.12.027_bib31","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0008-6363(02)00723-X","article-title":"Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure","volume":"57","author":"Frantz","year":"2003","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.mehy.2009.12.027_bib32","doi-asserted-by":"crossref","first-page":"H20","DOI":"10.1152\/ajpheart.00082.2005","article-title":"Inhibition of NF-kappaB induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats","volume":"289","author":"Gupta","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"18","key":"10.1016\/j.mehy.2009.12.027_bib33","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1161\/01.CIR.0000164237.58200.5A","article-title":"Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo","volume":"111","author":"Freund","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.mehy.2009.12.027_bib34","doi-asserted-by":"crossref","first-page":"H530","DOI":"10.1152\/ajpheart.00549.2006","article-title":"Inhibition of NF-{kappa}B improves left ventricular remodeling and cardiac dysfunction after myocardial infarction","volume":"292","author":"Onai","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1016\/j.mehy.2009.12.027_bib35","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jacc.2007.03.041","article-title":"Role of Rac1 GTPase activation in atrial fibrillation","volume":"50","author":"Adam","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.mehy.2009.12.027_bib36","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/CIRCULATIONAHA.105.538108","article-title":"Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases","volume":"112","author":"Dudley","year":"2005","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.mehy.2009.12.027_bib37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/01.RES.0000183735.09871.61","article-title":"A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation","volume":"97","author":"Kim","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.mehy.2009.12.027_bib38","unstructured":"Dudley S. Redox regulation, NF-kappaB, and atrial fibrillation. Antioxid Redox Signal 2009."},{"issue":"1","key":"10.1016\/j.mehy.2009.12.027_bib39","doi-asserted-by":"crossref","first-page":"C372","DOI":"10.1152\/ajpcell.00186.2007","article-title":"NF-kappaB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II","volume":"294","author":"Shang","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"10.1016\/j.mehy.2009.12.027_bib40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jvs.2008.03.004","article-title":"Prolonged increases in vein wall tension increase matrix metalloproteinases and decrease constriction in rat vena cava: potential implications in varicose veins","volume":"48","author":"Raffetto","year":"2008","journal-title":"J Vasc Surg"},{"issue":"3","key":"10.1016\/j.mehy.2009.12.027_bib41","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/157016108784911957","article-title":"Matrix metalloproteinases in venous tissue remodeling and varicose vein formation","volume":"6","author":"Raffetto","year":"2008","journal-title":"Curr Vasc Pharmacol"},{"issue":"5","key":"10.1016\/j.mehy.2009.12.027_bib42","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jvs.2008.06.056","article-title":"Metalloproteinase expression in venous aneurysms","volume":"48","author":"Irwin","year":"2008","journal-title":"J Vasc Surg"},{"issue":"10","key":"10.1016\/j.mehy.2009.12.027_bib43","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI13350","article-title":"Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy","volume":"108","author":"Takemoto","year":"2001","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.mehy.2009.12.027_bib44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/smim.2000.0210","article-title":"The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling","volume":"12","author":"Karin","year":"2000","journal-title":"Semin Immunol"},{"issue":"21","key":"10.1016\/j.mehy.2009.12.027_bib45","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1038\/sj.emboj.7600391","article-title":"Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers","volume":"23","author":"Bonizzi","year":"2004","journal-title":"EMBO J"},{"issue":"52","key":"10.1016\/j.mehy.2009.12.027_bib46","doi-asserted-by":"crossref","first-page":"52598","DOI":"10.1074\/jbc.M308941200","article-title":"Tyrosine kinase p56lck regulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IkappaBalpha following hypoxia\/reoxygenation","volume":"278","author":"Mahabeleshwar","year":"2003","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.mehy.2009.12.027_bib47","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/toxsci\/kfj096","article-title":"Src tyrosine kinases mediate crystalline silica-induced NF-kappaB activation through tyrosine phosphorylation of IkappaB-alpha and p65 NF-kappaB in RAW 264.7 macrophages","volume":"90","author":"Kang","year":"2006","journal-title":"Toxicol Sci"},{"issue":"51","key":"10.1016\/j.mehy.2009.12.027_bib48","doi-asserted-by":"crossref","first-page":"53725","DOI":"10.1074\/jbc.M407627200","article-title":"Transglutaminase 2 induces nuclear factor-kappaB activation via a novel pathway in BV-2 microglia","volume":"279","author":"Lee","year":"2004","journal-title":"J Biol Chem"},{"issue":"22","key":"10.1016\/j.mehy.2009.12.027_bib49","doi-asserted-by":"crossref","first-page":"10936","DOI":"10.1158\/0008-5472.CAN-06-1521","article-title":"Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation","volume":"66","author":"Kim","year":"2006","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.mehy.2009.12.027_bib50","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/emboj\/cdg139","article-title":"Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1)","volume":"22","author":"Vermeulen","year":"2003","journal-title":"EMBO J"},{"issue":"5535","key":"10.1016\/j.mehy.2009.12.027_bib51","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.1062374","article-title":"Duration of nuclear NF-kappaB action regulated by reversible acetylation","volume":"293","author":"Chen","year":"2001","journal-title":"Science"},{"issue":"45","key":"10.1016\/j.mehy.2009.12.027_bib52","doi-asserted-by":"crossref","first-page":"17345","DOI":"10.1073\/pnas.0806198105","article-title":"NFkappaB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions","volume":"105","author":"Yang","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.mehy.2009.12.027_bib53","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2337\/diabetes.49.11.1939","article-title":"High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells","volume":"49","author":"Inoguchi","year":"2000","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.mehy.2009.12.027_bib54","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.physbeh.2007.12.002","article-title":"Muscular diacylglycerol metabolism and insulin resistance","volume":"94","author":"Timmers","year":"2008","journal-title":"Physiol Behav"},{"issue":"2","key":"10.1016\/j.mehy.2009.12.027_bib55","doi-asserted-by":"crossref","first-page":"E405","DOI":"10.1152\/ajpendo.00378.2004","article-title":"PKC-delta-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice: role for NADPH oxidase","volume":"288","author":"Talior","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.mehy.2009.12.027_bib56","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"J Clin Invest"},{"issue":"50","key":"10.1016\/j.mehy.2009.12.027_bib57","doi-asserted-by":"crossref","first-page":"48115","DOI":"10.1074\/jbc.M209459200","article-title":"Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex","volume":"277","author":"Gao","year":"2002","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.mehy.2009.12.027_bib58","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI11559","article-title":"Prevention of fat-induced insulin resistance by salicylate","volume":"108","author":"Kim","year":"2001","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2009.12.027_bib59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-5793(03)00972-4","article-title":"Phosphorylation of insulin receptor substrate-1 serine 307 correlates with JNK activity in atrophic skeletal muscle","volume":"553","author":"Hilder","year":"2003","journal-title":"FEBS Lett"},{"issue":"5249","key":"10.1016\/j.mehy.2009.12.027_bib60","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1126\/science.271.5249.665","article-title":"IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance","volume":"271","author":"Hotamisligil","year":"1996","journal-title":"Science"},{"issue":"17","key":"10.1016\/j.mehy.2009.12.027_bib61","doi-asserted-by":"crossref","first-page":"17070","DOI":"10.1074\/jbc.M312021200","article-title":"Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner","volume":"279","author":"de","year":"2004","journal-title":"J Biol Chem"},{"issue":"5174","key":"10.1016\/j.mehy.2009.12.027_bib62","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kappa B by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"issue":"6706","key":"10.1016\/j.mehy.2009.12.027_bib63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta","volume":"396","author":"Yin","year":"1998","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.mehy.2009.12.027_bib64","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00007691-198512000-00012","article-title":"Effects of salsalate (nonacetylated salicylate) and aspirin on serum prostaglandins in humans","volume":"7","author":"Morris","year":"1985","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.mehy.2009.12.027_bib65","doi-asserted-by":"crossref","unstructured":"Shimokawa T, Smith WL. Prostaglandin endoperoxide synthase. The aspirin acetylation region. J Biol Chem 1992;267(17):12387-92.","DOI":"10.1016\/S0021-9258(19)49852-9"},{"issue":"Suppl","key":"10.1016\/j.mehy.2009.12.027_bib66","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0090-6980(81)90130-1","article-title":"Gastric cytoprotection by sodium salicylate","volume":"21","author":"Robert","year":"1981","journal-title":"Prostaglandins"},{"issue":"4","key":"10.1016\/j.mehy.2009.12.027_bib67","first-page":"617","article-title":"Salsalate, a nonacetylated salicylate, is as efficacious as diclofenac in patients with rheumatoid arthritis","volume":"22","author":"Bombardier","year":"1995","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.mehy.2009.12.027_bib68","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/CIRCULATIONAHA.108.804294","article-title":"Nuclear factor-{kappa}B activation contributes to vascular endothelial dysfunction via oxidative stress in overweight\/obese middle-aged and older humans","volume":"119","author":"Pierce","year":"2009","journal-title":"Circulation"},{"issue":"5535","key":"10.1016\/j.mehy.2009.12.027_bib69","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.1061620","article-title":"Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta","volume":"293","author":"Yuan","year":"2001","journal-title":"Science"},{"issue":"Suppl. 3","key":"10.1016\/j.mehy.2009.12.027_bib70","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1038\/sj.ijo.0802501","article-title":"Inflammation and the IKK beta\/I kappa B\/NF-kappa B axis in obesity- and diet-induced insulin resistance","volume":"27","author":"Shoelson","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"2","key":"10.1016\/j.mehy.2009.12.027_bib71","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB","volume":"11","author":"Cai","year":"2005","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.mehy.2009.12.027_bib72","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1752-8062.2008.00026.x","article-title":"Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes","volume":"1","author":"Goldfine","year":"2008","journal-title":"Clin Transl Sci"},{"issue":"2","key":"10.1016\/j.mehy.2009.12.027_bib73","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2337\/dc07-1338","article-title":"Salsalate improves glycemia and inflammatory parameters in obese young adults","volume":"31","author":"Fleischman","year":"2008","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.mehy.2009.12.027_bib74","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00125-008-1239-x","article-title":"The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study","volume":"52","author":"Koska","year":"2009","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.mehy.2009.12.027_bib75","doi-asserted-by":"crossref","first-page":"H1850","DOI":"10.1152\/ajpheart.01199.2008","article-title":"Feed-forward signaling of TNF-alpha and NF-kappaB via IKK-beta pathway contributes to insulin resistance and coronary arteriolar dysfunction in type 2 diabetic mice","volume":"296","author":"Yang","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.mehy.2009.12.027_bib76","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1677\/JOE-07-0005","article-title":"Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo","volume":"195","author":"Park","year":"2007","journal-title":"J Endocrinol"},{"issue":"4","key":"10.1016\/j.mehy.2009.12.027_bib77","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2174\/1389450054021927","article-title":"NAD(P)H oxidase activation: a potential target mechanism for diabetic vascular complications, progressive beta-cell dysfunction and metabolic syndrome","volume":"6","author":"Inoguchi","year":"2005","journal-title":"Curr Drug Targets"},{"issue":"12","key":"10.1016\/j.mehy.2009.12.027_bib78","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1001\/jama.298.12.1398-b","article-title":"Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes","volume":"298","author":"Inoguchi","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2009.12.027_bib79","doi-asserted-by":"crossref","unstructured":"McCarty MF, Inoguchi T, Targeting oxidative stress as a strategy for preventing vascular complications of diabetes and metabolic syndrome. In: Pasupuleti VK, Anderson JW, editors. Nutraceuticals, glycemic health, and type 2 diabetes. Wiley, Blackwell; 2008.","DOI":"10.1002\/9780813804149.ch11"},{"issue":"2","key":"10.1016\/j.mehy.2009.12.027_bib80","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/db06-0789","article-title":"Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy","volume":"56","author":"Zheng","year":"2007","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.mehy.2009.12.027_bib81","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.2337\/diabetes.51.7.2241","article-title":"Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes","volume":"51","author":"Romeo","year":"2002","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.mehy.2009.12.027_bib82","first-page":"1624","article-title":"Suppression of retinal neovascularization by the NF-kappaB inhibitor pyrrolidine dithiocarbamate in mice","volume":"40","author":"Yoshida","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7349","key":"10.1016\/j.mehy.2009.12.027_bib83","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0140-6736(64)90008-X","article-title":"Diabetic retinopathy and rheumatoid arthritis","volume":"2","author":"Powell","year":"1964","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.mehy.2009.12.027_bib84","first-page":"1019","article-title":"Diabetic retinopathy and salicylates","volume":"4","author":"Carroll","year":"1972","journal-title":"Ann Ophthalmol"},{"issue":"4","key":"10.1016\/j.mehy.2009.12.027_bib85","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diabetes.38.4.491","article-title":"Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial","volume":"38","author":"The DAMAD Study Group","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2009.12.027_bib86","doi-asserted-by":"crossref","unstructured":"Early Treatment Diabetic Retinopathy Study Research Group. Effects of aspirin treatment on diabetic retinopathy. ETDRS report number 8. Ophthalmology 1991;98(5 Suppl.):757\u201365.","DOI":"10.1016\/S0161-6420(13)38010-5"},{"issue":"2","key":"10.1016\/j.mehy.2009.12.027_bib87","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1620\/tjem.206.163","article-title":"Nuclear factor-kappaB activation in diabetic rat kidney: evidence for involvement of P-selectin in diabetic nephropathy","volume":"206","author":"Iwamoto","year":"2005","journal-title":"Tohoku J Exp Med"},{"issue":"9","key":"10.1016\/j.mehy.2009.12.027_bib88","first-page":"605","article-title":"The effect of inhibiting nuclear factor-kappa B on the diabetic nephropathy","volume":"41","author":"Ding","year":"2002","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"12","key":"10.1016\/j.mehy.2009.12.027_bib89","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s001250051567","article-title":"High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-kappa B-dependent","volume":"43","author":"Park","year":"2000","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.mehy.2009.12.027_bib90","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/138945008783431718","article-title":"Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway","volume":"9","author":"Cameron","year":"2008","journal-title":"Curr Drug Targets"},{"issue":"3","key":"10.1016\/j.mehy.2009.12.027_bib91","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2165\/00024677-200403030-00005","article-title":"Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review","volume":"3","author":"Ziegler","year":"2004","journal-title":"Treat Endocrinol"},{"issue":"1","key":"10.1016\/j.mehy.2009.12.027_bib92","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/emm.2007.12","article-title":"Alpha-lipoic acid inhibits matrix metalloproteinase-9 expression by inhibiting NF-kappaB transcriptional activity","volume":"39","author":"Kim","year":"2007","journal-title":"Exp Mol Med"},{"issue":"3","key":"10.1016\/j.mehy.2009.12.027_bib93","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1010-7940(97)00318-7","article-title":"Endothelial cell injury in cardiac surgery: salicylate may be protective by reducing expression of endothelial adhesion molecules","volume":"13","author":"Zund","year":"1998","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"10.1016\/j.mehy.2009.12.027_bib94","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/092986707779941113","article-title":"NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer","volume":"14","author":"Calzado","year":"2007","journal-title":"Curr Med Chem"},{"issue":"4 Suppl. 2","key":"10.1016\/j.mehy.2009.12.027_bib95","first-page":"11","article-title":"Reduced risk of NSAID gastropathy (GI mucosal toxicity) with nonacetylated salicylate (salsalate): an endoscopic study","volume":"19","author":"Roth","year":"1990","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.mehy.2009.12.027_bib96","doi-asserted-by":"crossref","unstructured":"Brien JA. Ototoxicity associated with salicylates. A brief review. Drug Saf 1993;9(2):143-8.","DOI":"10.2165\/00002018-199309020-00006"},{"issue":"9","key":"10.1016\/j.mehy.2009.12.027_bib97","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1523\/JNEUROSCI.23-09-03944.2003","article-title":"Salicylate induces tinnitus through activation of cochlear NMDA receptors","volume":"23","author":"Guitton","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2009.12.027_bib98","doi-asserted-by":"crossref","unstructured":"Lu YG, Tang ZQ, Ye ZY, Wang HT, Huang YN, Zhou KQ, et al. Salicylate, an aspirin metabolite, specifically inhibits the current mediated by glycine receptors containing alpha1-subunits. Br J Pharmacol 2009.","DOI":"10.1111\/j.1476-5381.2009.00321.x"},{"issue":"2","key":"10.1016\/j.mehy.2009.12.027_bib99","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.neuropharm.2007.10.017","article-title":"The aspirin metabolite salicylate enhances neuronal excitation in rat hippocampal CA1 area through reducing GABAergic inhibition","volume":"54","author":"Gong","year":"2008","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.mehy.2009.12.027_bib100","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.biopha.2005.01.011","article-title":"Inhibition of inflammatory cytokine secretion from mouse microglia cells by DHMEQ, an NF-kappaB inhibitor","volume":"59","author":"Takatsuna","year":"2005","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.mehy.2009.12.027_bib101","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1471-4159.2003.01684.x","article-title":"Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders","volume":"85","author":"Chiarugi","year":"2003","journal-title":"J Neurochem"},{"issue":"47","key":"10.1016\/j.mehy.2009.12.027_bib102","doi-asserted-by":"crossref","first-page":"18754","DOI":"10.1073\/pnas.0704908104","article-title":"Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson\u2019s disease","volume":"104","author":"Ghosh","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.mehy.2009.12.027_bib103","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0306-4522(00)00158-5","article-title":"The aspirin metabolite sodium salicylate causes focal cerebral hemorrhage and cell death in rats with kainic acid-induced seizures","volume":"99","author":"Najbauer","year":"2000","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.mehy.2009.12.027_bib104","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-3083.2003.01246.x","article-title":"Antigen presentation by murine dendritic cells is nuclear factor-kappa B dependent both in vitro and in vivo","volume":"58","author":"Yoshimura","year":"2003","journal-title":"Scand J Immunol"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2009.12.027_bib105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.febslet.2004.10.065","article-title":"A new NF-kappaB inhibitor attenuates a TH1 type immune response in a murine model","volume":"578","author":"Kabashima","year":"2004","journal-title":"FEBS Lett"},{"issue":"4","key":"10.1016\/j.mehy.2009.12.027_bib106","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1089\/jmf.2007.621","article-title":"Clinical potential of Spirulina as a source of phycocyanobilin","volume":"10","author":"McCarty","year":"2007","journal-title":"J Med Food"},{"key":"10.1016\/j.mehy.2009.12.027_bib107","doi-asserted-by":"crossref","unstructured":"McCarty MF, Barroso-Aranda J, Contreras F. High-dose folate and dietary purines promote scavenging of peroxynitrite-derived radicals \u2013 clinical potential in inflammatory disorders. Med Hypotheses 2009.","DOI":"10.1016\/j.mehy.2008.09.058"},{"key":"10.1016\/j.mehy.2009.12.027_bib108","doi-asserted-by":"crossref","unstructured":"McCarty MF. Practical prevention of cardiac remodelling and atrial fibrillation with full-spectrum antioxidant therapy and ancillary strategies. Med Hypotheses 2010, in press.","DOI":"10.1016\/j.mehy.2009.12.025"},{"issue":"2","key":"10.1016\/j.mehy.2009.12.027_bib109","first-page":"80","article-title":"Salsalate: its role in the management of rheumatic disease","volume":"3","author":"Singleton","year":"1980","journal-title":"Clin Ther"},{"issue":"11","key":"10.1016\/j.mehy.2009.12.027_bib110","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/jps.2600731147","article-title":"Metabolism of salsalate in normal subjects","volume":"73","author":"Dromgoole","year":"1984","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.mehy.2009.12.027_bib111","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0149-2918(95)80061-1","article-title":"Assessment of salsalate, a nonacetylated salicylate, in the treatment of patients with arthritis","volume":"17","author":"Atkinson","year":"1995","journal-title":"Clin Ther"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709008391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709008391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T16:56:57Z","timestamp":1685379417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987709008391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":111,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0306987709008391"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2009.12.027","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}